Our data clearly show that the LASP1 gene is not amplified in the vast majority of human breast cancers (only 1 out of 64 cases), suggesting that LASP-1 overexpression is mediated through transcriptional regulation rather than gene amplification. This evidence concerns the gene LASP1 and breast cancer.